Mirum Pharmaceuticals (MIRM) announced that its partner, Takeda (TAK), has received approval by the Japanese Ministry of Health, Labour, and ...

Rigel Pharmaceuticals (RIGL) announced that it has entered into a settlement agreement with Annora Pharma Private Ltd., Hetero Labs Ltd., and ...

GIFT Nifty was trading lower at 23,502, which indicates a negative start for domestic indices. Here are the top stocks to ...

As Anant Ambani’s wedding anniversary approaches, we take a look at the staggering wealth of Mukesh and Nita Ambani’s in-laws ...

From the Piramals and Mehtas to the Mariwalas and Mittals, the Ambanis are connected to large business empires of India.

Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the ...

Piramal Critical Care and BrePco Biopharma received UK approval for Neoatricon, a paediatric Dopamine Hydrochloride solution.

Nandini Piramal says the CDMO business, which contributed 58% of revenues in FY24, aspires to grow as a $1.2 billion business with a 25% EBITDA margin by 2030 ...

Psychiatry was once big business for pharma, with drugs like Prozac making billions. Now a few breakthroughs are reviving ...

Bajaj Broking has recommended two stocks that could see a 16% upside in the next 12 months amid a market correction that has seen Sensex and Nifty on a downward trend.

Samuel S Chowdhury, chairman of Square Pharmaceuticals, yesterday expressed his willingness to purchase 15 lakh shares of the company, valued at over Tk 32 crore at the current market price.

This collective initiative aims to advance India’s CRDMO sector and is dedicated to fostering pharmaceutical and healthcare ...